AbCellera Biologics Inc.ABCLNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank29
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P29
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-155.42M+23.9%
2024$-204.15M-6.2%
2023$-192.16M-173.9%
2022$260.17M+8.8%
2021$239.15M+41.0%
2020$169.62M+109529.0%
2019$-155000.00-110.8%
2018$1.44M-